TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1824653

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 54
Study: 6346782

Group type: EXPERIMENTAL
Intervention: Cimethidine 400 mg intramuscularly as pre-anesthetic
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cimethidine group
Number of subjects: 20
Study: 31248751

Group type: EXPERIMENTAL
Intervention: NSE pre-dilatation
Number of subjects: 210

Group type: COMPARATOR
Intervention: High pressure non-compliant balloon pre-dilatation (POBA)
Number of subjects: 210
Study: 29121432

Group type: EXPERIMENTAL
Intervention: Alpine climate treatment (6-week personalized integrative multidisciplinary treatment in Switzerland)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Outpatient treatment in moderate maritime climate (Netherlands)
Number of subjects: 84
Study: 27838673

Group type: EXPERIMENTAL
Intervention: Tdap (tetanus, diphtheria, and acellular pertussis) vaccination
Number of subjects: 67

Group type: COMPARATOR
Intervention: Tetanus-only vaccination
Number of subjects: 67
Study: 24727871

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 60

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both on-pump and off-pump CABG
Number of subjects: 60
Study: 21636667

Group type: EXPERIMENTAL
Intervention: Fluticasone/Salmeterol combination (FP/SM) 125/25 μg, two puffs bid for 2 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fluticasone (250 μg), two puffs bid for 2 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fluticasone/Salmeterol combination (FP/SM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fluticasone (250 μg)
Number of subjects: 31
Study: 20237772

Group type: EXPERIMENTAL
Intervention: 900 mg/day OXC
Number of subjects: 27

Group type: COMPARATOR
Intervention: 600 mg/day CBZ
Number of subjects: 27
Study: 17612907

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study: 15196300

Group type: EXPERIMENTAL
Intervention: Valproate 1000 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11521982

Group type: EXPERIMENTAL
Intervention: Antibodies to H. pylori in Group A (S-PGI <25 microg/l) and Group C (S-PGI >100 microg/l)
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Antibodies to CagA in relation to S-PGI levels
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: Antibodies to CagA in relation to severity of atrophic gastritis
Number of subjects: 953
Study: 9475824

Group type: EXPERIMENTAL
Intervention: Zinc lozenges (zinc gluconate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8709604

Group type: EXPERIMENTAL
Intervention: Guyin Decoction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 60
Study: 2501852

Group type: EXPERIMENTAL
Intervention: Au parenteral preparations
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: D-penicillamine (average daily dose of 450 mg)
Number of subjects: 213
Study: 78625

Group type: EXPERIMENTAL
Intervention: Trioxsalen baths (0.5 mg/1) for 15 minutes followed by irradiation with dysprosium lamps (Osram HQI‐TS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ingram method (control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Methoxsalen bath (1 mg/l)
Number of subjects: 18
Study: 30059354

Group type: EXPERIMENTAL
Intervention: Virtual reality intervention
Number of subjects: 49
Study: 27076220

Group type: EXPERIMENTAL
Intervention: CoCr-BAS
Number of subjects: 40

Group type: COMPARATOR
Intervention: PtCr-EES
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 25339740

Group type: EXPERIMENTAL
Intervention: Antisaccade task in ALS patients during fMRI
Number of subjects: 12

Group type: COMPARATOR
Intervention: Antisaccade task in age-matched controls during fMRI
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Saccadic latencies in ALS patients during fMRI
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DLPFC activation during antisaccade preparation in ALS patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Increased activation in supplementary eye fields and frontal eye fields in ALS patients
Number of subjects: 12
Study: 23097397

Group type: EXPERIMENTAL
Intervention: Bt maize-fed offspring from Bt maize-fed sows
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bt maize-fed pigs
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pigs in the Bt/Bt group
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Offspring from Bt maize-fed sows
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pigs on the Bt/Bt treatment
Number of subjects: 15
Study: 20394489

Group type: EXPERIMENTAL
Intervention: Mometasone cream (0.1%) once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pimecrolimus cream (1%) twice daily
Number of subjects: 50
Study: 18410774

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 15101860

Group type: EXPERIMENTAL
Intervention: Pre group (promethazine 0.1 mg kg(‐1) before anaesthesia)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Post group (saline before anaesthesia, promethazine 0.1 mg kg(‐1) postoperatively)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (two equivalent volumes of saline)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pre group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Post group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 12448315

Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medically treated patients
Number of subjects: 90
Study: 11273253

Group type: EXPERIMENTAL
Intervention: Polyunsaturated phosphatidyl choline (PPC) 350 mg thrice daily for 6 to 8 weeks
Number of subjects: 0
Study: 7650662

Group type: EXPERIMENTAL
Intervention: Patient-determined reintroduction of solid food within eight hours of surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional gradual dietary expansion regimen
Number of subjects: 0
Study: 2560583

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prophylactic brain irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extensive irradiation
Number of subjects: 0
Study: 807697

Group type: EXPERIMENTAL
Intervention: Continuous nasojejunal feeding
Number of subjects: 21

Group type: COMPARATOR
Intervention: Intermittent nasogastric feeding
Number of subjects: 21
Study: 30825908

Group type: EXPERIMENTAL
Intervention: Intravenous labetalol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral nifedipine
Number of subjects: 30
Study: 28632558

Group type: EXPERIMENTAL
Intervention: miTLIF (minimally invasive transforaminal lumbar interbody fusion)
Number of subjects: 187

Group type: COMPARATOR
Intervention: oTLIF (open transforaminal lumbar interbody fusion)
Number of subjects: 187
Study: 25986223

Group type: EXPERIMENTAL
Intervention: Aerobic walking exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Internal control group (treadmill exercise)
Number of subjects: 60
Study: 23989054

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 217
Study: 22070475

Group type: EXPERIMENTAL
Intervention: Prednisolone plus N-acetylcysteine
Number of subjects: 174

Group type: COMPARATOR
Intervention: Prednisolone only
Number of subjects: 174
Study: 18515458

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lithium-valproate combination
Number of subjects: 55

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 55
Study: 16685043

Group type: EXPERIMENTAL
Intervention: Chicken diet (CD)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Lactovegetarian low‐protein diet (LPD)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Usual diet (UD)
Number of subjects: 17
Study: 15573688

Group type: EXPERIMENTAL
Intervention: Amorolfine nail lacquer
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ciclopirox nail lacquer
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tioconazole nail lacquer
Number of subjects: 10
Study: 11360058

Group type: EXPERIMENTAL
Intervention: Gasless laparoscopic cholecystectomy (GLC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 50
Study: 9421839

Group type: EXPERIMENTAL
Intervention: Self-controlled knowledge of performance (SELF)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Summary knowledge of performance (SUMMARY)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Yoked control (YOKE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Knowledge of results only (KR)
Number of subjects: 48
Study: 7956585

Group type: EXPERIMENTAL
Intervention: Closed technique (surgical excision and primary closure, Group A)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Open technique (Obeid's surgical excision, Group B)
Number of subjects: 110
Study: 3312614

Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 0
Study: 31655119

Group type: EXPERIMENTAL
Intervention: UCBT
Number of subjects: 45

Group type: COMPARATOR
Intervention: haplo‐SCT
Number of subjects: 45
Study: 30142868

Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐α‐2b and ADV
Number of subjects: 102

Group type: COMPARATOR
Intervention: PEG‐IFN‐α‐2b alone
Number of subjects: 102
Study: 27723839

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sham ischemic preconditioning (Control)
Number of subjects: 102
Study: 24516190

Group type: EXPERIMENTAL
Intervention: ABT‐288 10mg
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: ABT‐288 25mg
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 21940765

Group type: EXPERIMENTAL
Intervention: One-page patient-specific feedback form based on questionnaire responses to stimulate conversations about end-of-life care.
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (no feedback form), completed questionnaires but did not receive feedback.
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: One-page patient-specific feedback form.
Number of subjects: 376
Study: 21111100

Group type: EXPERIMENTAL
Intervention: Moderate-carbohydrate lunch meal
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-carbohydrate lunch meal
Number of subjects: 14
Study: 17972110

Group type: EXPERIMENTAL
Intervention: d‐methylphenidate (d‐MPH)
Number of subjects: 57

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 57
Study: 15113946

Group type: EXPERIMENTAL
Intervention: Iron-fortified infant cereals with regular or low phytate content
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron-fortified infant formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron intake from 12 to 17 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron intake from 6 to 11 months
Number of subjects: 0
Study: 11688904

Group type: EXPERIMENTAL
Intervention: Interferon-alpha with amantadine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Interferon-alpha monotherapy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Interferon-alpha with or without amantadine
Number of subjects: 8
Study: 9153520

Group type: EXPERIMENTAL
Intervention: Chronic alcoholics
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 40
Study: 7701056

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (age- and gender-matched)
Number of subjects: 15
Study: 3300975

Group type: EXPERIMENTAL
Intervention: 25 mg isosorbide 5‐mononitrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 50 mg isosorbide 5‐mononitrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100 mg isosorbide 5‐mononitrate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31488733

Group type: EXPERIMENTAL
Intervention: Noradrenergic and serotonergic antidepressants with 100 mg acetylsalicylic acid (ASA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Noradrenergic and serotonergic antidepressants without 100 mg acetylsalicylic acid (ASA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Noradrenergic and serotonergic antidepressants (both with and without ASA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy group (HG)
Number of subjects: 40
Study: 29150395

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 55
Study: 26493551

Group type: COMPARATOR
Intervention: Bipolar coagulation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Suturing
Number of subjects: 109
Study: 24568225

Group type: EXPERIMENTAL
Intervention: Pickle Juice (PJ)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hypertonic Saline
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Deionized Water (DIW)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Pre-exercise
Number of subjects: 9
Study: 23082941

Group type: EXPERIMENTAL
Intervention: Teacher-made models (TM)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Commercial model (CM)
Number of subjects: 144
Study: 20338501

Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell therapy (BMC therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BMCs contaminated with RBCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolated BMCs with added RBCs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher numbers of RBCs in BMC preparation
Number of subjects: 0
Study: 17403067

Group type: EXPERIMENTAL
Intervention: First offender incarceration and treatment program
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group (only incarcerated)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: First offender incarceration and treatment program (for ASPD participants)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group (for ASPD participants)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: First offender incarceration and treatment program (relative to control)
Number of subjects: 305
Study: 15831714

Group type: EXPERIMENTAL
Intervention: Electrical acupoint stimulation at the Neiguan
Number of subjects: 14

Group type: COMPARATOR
Intervention: Naloxone (80 microg/kg iv bolus injection)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham point stimulation
Number of subjects: 14
Study: 11407429

Group type: EXPERIMENTAL
Intervention: Pseudohomophones with extant body rime relations
Number of subjects: 0
Study: 9406270

Group type: EXPERIMENTAL
Intervention: Structured assessment of long-term mentally ill patients every six months
Number of subjects: 16

Group type: COMPARATOR
Intervention: General practitioner consultations
Number of subjects: 16
Study: 8220037

Group type: EXPERIMENTAL
Intervention: High-resolution sonographically guided catheterization
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional right internal jugular vein catheterization
Number of subjects: 47
Study: 3323167

Group type: EXPERIMENTAL
Intervention: roxithromycin (150 mg bd)
Number of subjects: 76

Group type: COMPARATOR
Intervention: doxycycline (200 mg once daily)
Number of subjects: 76
Study: 30935544

Group type: EXPERIMENTAL
Intervention: Dynamic neuro-cognitive imagery (DNI) training
Number of subjects: 20

Group type: COMPARATOR
Intervention: In-home learning and exercise control
Number of subjects: 20
Study: 29445655

Group type: EXPERIMENTAL
Intervention: Nonextensible lumbosacral orthosis (LSO) in addition to routine physical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine physical therapy
Number of subjects: 0
Study: 25458446

Group type: EXPERIMENTAL
Intervention: Ultrasound and electrical stimulator guided obturator nerve block using 5% phenol in aqueous solution
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 26
Study: 23867158

Group type: EXPERIMENTAL
Intervention: Telephone- and Skype-based dietary counseling
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control condition providing print materials only
Number of subjects: 48
Study: 20817628

Group type: EXPERIMENTAL
Intervention: Working in agriculture
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Working in livestock farming
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Exposure to pesticides
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Exposure to fertilizers
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Exposure to disinfectants
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Exposure to salt based wood protection agents
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Working with plywood
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Working with coated wood
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Working in forestry
Number of subjects: 188
Study: 18346173

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (dietary counselling only)
Number of subjects: 60
Study: 16568505

Group type: EXPERIMENTAL
Intervention: Abatacept 10 mg/kg
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Abatacept 2 mg/kg
Number of subjects: 339

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study: 12945222

Group type: EXPERIMENTAL
Intervention: Bisoprolol 2.5 mg/HCTZ 6.25 mg
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg/HCTZ 6.25 mg
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Continuation with Bisoprolol 2.5 mg/HCTZ 6.25 mg for 4 more weeks
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Up-titration to Bisoprolol 5 mg/HCTZ 6.25 mg
Number of subjects: 641
Study: 10703152

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG)
Number of subjects: 0
Study: 9070520

Group type: EXPERIMENTAL
Intervention: Nailing after reaming
Number of subjects: 91

Group type: COMPARATOR
Intervention: Nailing without reaming
Number of subjects: 91

Group type: COMPARATOR
Intervention: Comparison of screws
Number of subjects: 91

Group type: COMPARATOR
Intervention: Functional outcomes
Number of subjects: 91
Study: 8373709

Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms orally)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Change from upright to supine position
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yohimbine (alpha 2‐adrenoceptor antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standing after yohimbine administration
Number of subjects: 0
Study: 31102320

Group type: EXPERIMENTAL
Intervention: Blunt Blade (BB) subcision
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nokor needle subcision
Number of subjects: 28
Study: 28766191

Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game (PAX GBG)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 811
Study: 26588822

Group type: EXPERIMENTAL
Intervention: Instruction with sham treatment (peppermint essence vapor)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Conditioning with sham treatment (peppermint essence vapor)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of instruction and conditioning
Number of subjects: 56
Study: 24509980

Group type: EXPERIMENTAL
Intervention: Allografts loaded with mesenchymal stem cells (MSCs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Allografts without mesenchymal stem cells (MSCs)
Number of subjects: 60
Study: 21193234

Group type: EXPERIMENTAL
Intervention: MDCT‐XTe (BMI‐adapted scanning protocol with prospective ECG‐triggering)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: MDCT‐XT (standard prospective ECG‐triggering protocol)
Number of subjects: 119

Group type: COMPARATOR
Intervention: MDCT‐Helical (retrospective ECG‐triggering)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Effective radiation dose for MDCT‐XTe
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Effective radiation dose for MDCT‐XT
Number of subjects: 119

Group type: COMPARATOR
Intervention: Effective radiation dose for MDCT‐Helical
Number of subjects: 119
Study: 20588189

Group type: EXPERIMENTAL
Intervention: AZD1305
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 18718419

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 400
Study: 15943841

Group type: EXPERIMENTAL
Intervention: famotidine 20 mg b.d. (n = 48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: omeprazole once daily (n = 50)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: famotidine
Number of subjects: 98

Group type: COMPARATOR
Intervention: omeprazole
Number of subjects: 98
Study: 14663351

Group type: EXPERIMENTAL
Intervention: Transiently evoked otoacoustic emissions (TEOAEs) and tympanometry included in the protocol
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group protocol (TEOAEs and tympanometry omitted)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 9927114

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 8736713

Group type: EXPERIMENTAL
Intervention: Heat-washout method
Number of subjects: 2

Group type: COMPARATOR
Intervention: 133Xe-washout method
Number of subjects: 2
Study: 1914097

Group type: EXPERIMENTAL
Intervention: Intensive 4-week in-hospital exercise program (training group with ejection fraction <30%)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intensive 4-week in-hospital exercise program (training group with ejection fraction 31-50%)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Minimal activity program (control group with ejection fraction <30%)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Minimal activity program (control group with ejection fraction 31-50%)
Number of subjects: 39